NEW YORK, May 11, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) (“NeoStem” or the “Company”), an international biopharmaceutical company focused on cell based therapies, today announced first quarter 2012 results and provided an update on its business.
